Maha Rashtra Apex Corporation Announces Rights Issue of Up to ₹1,409.19 Lakhs
Maha Rashtra Apex Corporation Limited has announced a rights issue of up to 1,40,91,896 equity shares at ₹10.00 per share, totaling up to ₹1,409.19 lakhs. The issue opens April 2, 2026 and closes April 30, 2026, with a 1:1 rights ratio for shareholders as on record date March 20, 2026. The company has published regulatory advertisements and filed the Letter of Offer with stock exchanges in compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Maha Rashtra Apex Corporation Limited has announced a rights issue of equity shares, publishing newspaper advertisements in compliance with SEBI regulations and setting the record date for eligible shareholders.
Rights Issue Details
The company has announced the issue of up to 1,40,91,896 equity shares of face value ₹10.00 each at an issue price of ₹10.00 per equity share, aggregating up to ₹1,409.19 lakhs. The rights issue will be offered to existing equity shareholders in the ratio of 1:1, meaning one rights equity share for every one fully paid-up equity share held on the record date.
| Parameter: | Details |
|---|---|
| Issue Size: | Up to 1,40,91,896 equity shares |
| Face Value: | ₹10.00 per share |
| Issue Price: | ₹10.00 per share |
| Total Amount: | Up to ₹1,409.19 lakhs |
| Rights Ratio: | 1:1 |
| Record Date: | March 20, 2026 |
Issue Timeline
The rights issue follows a structured timeline with specific dates for application and renunciation processes. The issue will remain open for 28 days, with the rights issue committee having the authority to extend the period up to 30 days from the opening date.
| Event: | Date |
|---|---|
| Issue Opens: | April 2, 2026 |
| Last Date for On-Market Renunciation: | April 24, 2026 |
| Issue Closes: | April 30, 2026 |
Application Process and Requirements
All investors must use the Application Supported by Blocked Amount (ASBA) process for applications in this issue, as mandated by SEBI ICDR Regulations. The rights entitlements will be credited to shareholders' demat accounts and will be tradable on stock exchanges under ISIN INE843B20013.
Key application requirements include:
- Mandatory use of ASBA process for all applications
- Rights entitlements credited in dematerialized form only
- Shareholders holding physical shares must provide demat account details at least two working days before issue closing date
- Applications can be made through designated branches of Self Certified Syndicate Banks (SCSBs)
Regulatory Compliance
The company has published newspaper advertisements on March 29, 2026, in compliance with Regulation 84 of SEBI ICDR Regulations. The advertisements were published in three newspapers:
- Financial Express (English) - National daily
- Janasatta (Hindi) - National daily
- Vishwani (Kannada) - Regional daily for registered office location
The Letter of Offer was filed with BSE Limited and National Stock Exchange on March 11, 2026, and is available on SEBI's website for public access.
Trading and Listing Information
The company's existing equity shares are currently listed and traded on BSE (Scrip Code: 523384) and NSE (Symbol: MAHAPEXLT) under ISIN INE843B01013. The rights equity shares will be credited to a temporary ISIN initially, which will be converted to the permanent ISIN upon receipt of final listing and trading approvals from stock exchanges.
Purva Sharegistry (India) Private Limited serves as the registrar to the issue, while ICICI Bank Limited acts as both the allotment account bank and refund bank for the rights issue.
Historical Stock Returns for Maha Rashtra Apex Corporation
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.13% | -11.66% | +1.67% | -10.85% | -14.12% | +35.96% |
How will the dilution from this 1:1 rights issue impact Maha Rashtra Apex Corporation's earnings per share and stock price performance?
What specific business expansion or debt reduction plans does the company have for the ₹1,409.19 lakhs raised through this rights issue?
Will the company's increased share capital post-rights issue affect its dividend policy and payout ratios in future quarters?






























